March 14, 2011

Argon to Distribute Rex Medical's Option IVC Filter

March 15, 2011—Argon Medical Devices, Inc. (Athens, TX) announced today that it has entered into a definitive license agreement with Rex Medical, LP (Conshohocken, PA) to market and distribute the Option retrievable inferior vena cava (IVC) filter.

 According to Argon, the nitinol Option IVC filter with a low-profile 5-F (6.5-F outer diameter) delivery system can be implanted into the IVC to prevent recurrent pulmonary embolism. The filter is designed with symmetric flared struts to direct clot volume into the center of the vessel for maximum dissolution and preservation of blood flow, allowing for capture of clinically significant clot and protection against pulmonary embolism. The device is designed to serve as either a permanent or retrievable implant, the company stated.

Subscribe to our weekly newsletter.

Stay informed on the week's top stories including literature summaries, device approvals, guideline changes, and more. Plus, get our latest issues & supplements delivered to your inbox each month.

March 14, 2011

Argon to Distribute Rex Medical's Option IVC Filter

Current Issue

Keep In Touch